ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

CYP4X1/sEH-Dependent Endocannabinoid Metabolism Drives Fibroblast-Mediated Immunosuppression to Limit Immunotherapy in Colon Cancer.

Min Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.